Relationship between monitoring parameters and perinatal outcome in severe, early intrauterine growth restriction

C M Bilardo1, H Wolf, R H Stigter

  • 1Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam, The Netherlands. C.M.Bilardo@AMC.UVA.NL

Insights

Ductus venosus pulsatility index (DV PIV) is the most effective predictor of adverse perinatal outcomes in severe early intrauterine growth restriction (IUGR). This finding can help optimize delivery timing for improved fetal health.

Area of Science:

  • Perinatal Medicine
  • Fetal Physiology
  • Neonatal Outcomes

Background:

  • Severe early intrauterine growth restriction (IUGR) poses significant risks to fetal well-being.
  • Monitoring fetal well-being in IUGR is crucial for timely intervention.
  • Existing monitoring methods require further validation for predicting perinatal outcomes.

Purpose of the Study:

  • To evaluate the predictive value of umbilical artery (UA) and ductus venosus (DV) Doppler parameters, along with short-term fetal heart rate variation (STV), for perinatal outcomes in severe early IUGR.
  • To determine the optimal timing for assessing these parameters in relation to delivery.

Main Methods:

  • A multicenter, prospective, observational study involving 70 singleton pregnancies with severe early IUGR.
  • Regular assessment of fetal heart rate STV, UA pulsatility index (UA PI), and DV pulsatility index for veins (DV PIV) up to 24 hours before delivery.
  • Adverse perinatal outcome defined as perinatal death, severe cerebral hemorrhage, or bronchopulmonary dysplasia.

Main Results:

  • Adverse perinatal outcome occurred in 26% of infants.
  • DV PIV was significantly higher in the adverse outcome group within 24 hours and 2-7 days before delivery.
  • DV PIV, adjusted for gestational age (GA), significantly predicted adverse outcomes at various time points (0-1, 2-7, and 8-14 days prior to delivery).

Conclusions:

  • DV PIV measurement is the strongest predictor of perinatal outcome in severe early IUGR.
  • DV PIV monitoring may aid in optimizing delivery timing to improve perinatal outcomes.
  • Further randomized trials are needed to confirm the clinical utility of DV PIV in managing IUGR pregnancies.
Abstract